Literature DB >> 6324996

Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image.

K Iwai, H Maeda, T Konno.   

Abstract

Highly malignant rabbit tumor (VX-2) was implanted at the periphery of the liver in 63 rabbits. Selective delivery of the anticancer agent copoly(styrenemaleic acid) conjugated to neocarzinostatin (SMANCS), which was dissolved in an oil contrast medium (Lipiodol), was performed by injection via the proper hepatic artery. The anticancer effect was also evaluated by various parameters. By using low-kVp X-ray examination of the resected rabbit liver, Lipiodol was found to distribute throughout the entire liver arterial lumina and was retained there for about 24 hr, but disappeared from the normal liver arterial lumina gradually. However, Lipiodol was retained in the tumor tissue and vessels for at least 7 days, whereas it was undetectable in any other organs. A radioactive analogue of Lipiodol, a chloroiodinated fatty acid, was prepared by using [14C]linoleic acid. This analogue was used in the study of the distribution by low-kVp X-ray examination, Sudan III staining, and autoradiography. Lipiodol remained in the tumor vessels as well as the tumor cells. The use of the radioisotope yielded a quantitative profile of Lipiodol accumulation in tumor tissues; approximately 1000 times more at 15 min and 100 times more at 3 days after the injection than that of most other organs or plasma. Its major excretion route appeared to be through the bile and then the feces. The biological activity of SMANCS was also determined and was found to be significant in both tumor and liver even 7 days after injection. No activity was found in any other organ or tissue. The relatively high biological activity of SMANCS in the nontumorous liver adjacent to the tumor may be the result of continuous drug release from SMANCS-Lipiodol in the tumor tissue. By histological examination, massive tumor necrosis and infiltration of the inflammatory cells were found in the rabbits treated with SMANCS-Lipiodol. In the rabbits treated with Lipiodol alone, necrosis of the tumor was only minimal, and no infiltration of inflammatory cells was observed. Survival periods of the treated rabbits (n = 14) were significantly longer than those of controls (n = 10); 23.1 +/- 5.5 (S.D.) days versus 16.1 +/- 2.9 days (p less than 0.005), respectively, even though only one injection was used for this highly malignant tumor. Mean tumor size for both groups at laparotomy was 163.3 +/- 83.0 sq mm and 160.5 +/- 76.5 sq mm, respectively (not significant).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324996

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  57 in total

1.  Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors.

Authors:  Jun Fang; Haibo Qin; Hideaki Nakamura; Kenji Tsukigawa; Takashi Shin; Hiroshi Maeda
Journal:  Cancer Sci       Date:  2012-01-16       Impact factor: 6.716

2.  Combined transarterial chemoembolization and arterial administration of Bletilla striata in treatment of liver tumor in rats.

Authors:  Jun Qian; Daryusch Vossoughi; Dirk Woitaschek; Elsie Oppermann; Wolf O Bechstein; Wei-Yong Li; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

3.  Effect of arterial administration of a high molecular weight anti-tumor agent, styrene maleic acid neocarzinostatin, for multiple small liver cancer--a pilot study.

Authors:  K Ikeda; S Saitoh; Y Suzuki; A Tsubota; I Koida; M Kobayashi; Y Arase; K Chayama; N Murashima; H Kumada
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 4.  Vascular targeting of nanoparticles for molecular imaging of diseased endothelium.

Authors:  Prabhani U Atukorale; Gil Covarrubias; Lisa Bauer; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2016-09-15       Impact factor: 15.470

5.  Pharmacokinetics of miriplatin in experimental dog models of hepatic or renal impairment.

Authors:  Atsushi Kitamura; Jin Shimakura; Masashi Yabuki; Hiroyuki Asano; Toshifumi Fukuoka; Minoru Nakano; Setsuko Komuro
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-08       Impact factor: 2.441

6.  Transcatheter arterial chemoembolization with anticancer drug in iodized oil for primary hepatic carcinoma.

Authors:  J Y Guo; D Yen; Z Z Huang; G D Hu; P C Liu
Journal:  Cardiovasc Intervent Radiol       Date:  1989 Jul-Aug       Impact factor: 2.740

Review 7.  Thermosensitive liposomes for localized delivery and triggered release of chemotherapy.

Authors:  Terence Ta; Tyrone M Porter
Journal:  J Control Release       Date:  2013-04-11       Impact factor: 9.776

8.  Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology.

Authors:  T Imaeda; Y Yamawaki; M Seki; H Goto; G Iinuma; M Kanematsu; R Mochizuki; H Doi; S Saji; K Shimokawa
Journal:  Cardiovasc Intervent Radiol       Date:  1993 Jul-Aug       Impact factor: 2.740

9.  Treatment of hepatic-metastatic colorectal cancer with a chemotherapeutic emulsion: interim results of a phase I trial.

Authors:  J T Rubin; M T Lotze; D Rosenfelder; A Brumfield; R Howells; R Schwartz; S Sylvestri; J Sammon; K Bron; P Orens
Journal:  Ann Surg Oncol       Date:  1995-07       Impact factor: 5.344

10.  Dynamics of different-sized solid-state nanocrystals as tracers for a drug-delivery system in the interstitium of a human tumor xenograft.

Authors:  Masaaki Kawai; Hideo Higuchi; Motohiro Takeda; Yoshio Kobayashi; Noriaki Ohuchi
Journal:  Breast Cancer Res       Date:  2009-07-03       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.